December 12, 2014 09:00 ET

Trilogy Energy Corp. Implements a Normal Course Issuer Bid

CALGARY, ALBERTA--(Marketwired - Dec. 12, 2014) - Trilogy Energy Corp. ("Trilogy") (TSX:TET) announces today that, further to its December 8th, 2014 news release, it has made the necessary filings, and received the necessary approvals, to make a normal course issuer bid through the facilities of the Toronto Stock Exchange ("TSX"). Trilogy may purchase up to 6,490,470 of its common shares ("Common Shares"), representing approximately 10% of the 64,904,707 public float outstanding as at December 1, 2014, for cancellation under the bid. As of December 1, 2014, the total issued and outstanding number of Common Shares was 105,150,110. Pursuant to section 628 of the TSX Company Manual, Trilogy is permitted under the bid to acquire up to 25 percent of the average daily trading volume, being 94,138 Common Shares, per day. Purchases under the bid may be made during the period beginning on December 16, 2014 and ending on December 15, 2015, or on such earlier date as Trilogy may complete its purchases under the bid. The price Trilogy will pay for any Common Shares purchased under the bid will be the market price at the time of purchase.

About Trilogy

Trilogy is a growing petroleum and natural gas-focused Canadian energy corporation that actively develops, produces and sells natural gas, crude oil and natural gas liquids. Trilogy's geographically concentrated assets are primarily high working interest properties that provide abundant low-risk infill drilling opportunities and good access to infrastructure and processing facilities, many of which are operated and controlled by Trilogy. Trilogy's common shares are listed on the Toronto Stock Exchange under the symbol "TET".

Contact Information

  • J.H.T. (Jim) Riddell, Chief Executive Officer
    J.B. (John) Williams, President and Chief Operating Officer
    M.G. (Mike) Kohut, Chief Financial Officer

    Trilogy Energy Corp.
    #1400, 332 - 6th Avenue S.W.
    Calgary, Alberta T2P 0B2
    (403) 290-2900
    (403) 263-8915 (FAX)